Lineage-dependence of the neuroblastoma surfaceome defines tumor cell state-dependent and independent immunotherapeutic targets
Nathan M. Kendsersky(Children's Hospital of Philadelphia), John M. Maris(Children's Hospital of Philadelphia)
Cited by 2
Related Papers
Chromosome 1p and 11q Deletions and Outcome in Neuroblastoma
|New England Journal of Medicine|2005|571
The B7-H3–Targeting Antibody–Drug Conjugate m276-SL-PBD Is Potently Effective Against Pediatric Cancer Preclinical Solid Tumor Models
|Clinical Cancer Research|2021|119